Diquafosol Ophthalmic Solution for Dry Eye Treatment

被引:0
作者
Masatsugu Nakamura
Takahiro Imanaka
Asuka Sakamoto
机构
[1] Santen Pharmaceutical Co.,Research and Development Division
[2] Ltd.,Research and Development Division
[3] Santen Pharmaceutical Co.,undefined
[4] Ltd.,undefined
来源
Advances in Therapy | 2012年 / 29卷
关键词
Diquafosol; Dry eye; Mucin secretion; Ocular surface; P2Y; receptor agonist; Short break-up time; Tear film instability; Water secretion;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:579 / 589
页数:10
相关论文
共 70 条
[1]  
Lemp M.A.(1995)Report of National Eye Institute/Industry Workshop on clinical trials in dry eyes CLAO J 21 221-232
[2]  
Shimazaki J.(1995)Dry Eye Research Group in Japan. Definition and criteria of dry eye Ganka 37 765-770
[3]  
DEWS members.(2007)2007 Report of the International Dry Eye Workshop (DEWS) Ocul Surf 5 65-204
[4]  
Shimazaki J.(2007)Dry Eye Research Group in Japan. Definition and diagnosis of dry eye 2006 J Eye 24 181-184
[5]  
Fahmy A.M.(2011)Treating ocular surface disease: new agents in development Clin Ophthalmol 5 465-472
[6]  
Hardten D.R.(2004)Diquafosol tetrasodium: A novel dry eye therapy Expert Opin Invest Drugs 13 47-54
[7]  
Nichols K.K.(2003)Localization of ocular P2Y Exp Eye Res 77 77-84
[8]  
Yerxa B.(2001) receptor gene expression by in situ hybridization Am J Physiol 281 C595-C602
[9]  
Kellerman D.J.(1998)Rabbit conjunctival epithelium transports fluid, and P2Y Exp Eye Res 67 341-346
[10]  
Cowlen M.S.(2011) receptor agonists stimulate Cl J Eye 28 1029-1033